• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实践中的 GOLD:初级保健环境中的慢性阻塞性肺疾病治疗和管理。

GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting.

机构信息

Department of Family and Community Health, University of Minnesota, Minneapolis, MN, USA.

COPD Foundation, Miami, FL, USA.

出版信息

Int J Chron Obstruct Pulmon Dis. 2021 Feb 12;16:289-299. doi: 10.2147/COPD.S222664. eCollection 2021.

DOI:10.2147/COPD.S222664
PMID:33603355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7886101/
Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality. Early detection and appropriate treatment and management of COPD can lower morbidity and perhaps mortality. Clinicians in the primary care setting provide the majority of COPD care and are pivotal in the diagnosis and management of COPD. In this review, we provide an overview of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 report, with a focus on the management of COPD in the primary care setting. We discuss the pathophysiology of COPD; describe COPD risk factors, signs, and symptoms that may facilitate earlier diagnosis of COPD; and reinforce the importance of spirometry use in establishing the diagnosis of COPD. Disease monitoring, as well as a review of the 2020 GOLD treatment recommendations, is also discussed. Patients and families are important partners in COPD management; therefore, we outline simple steps that may assist them in caring for those affected by COPD. Finally, we discuss nonpharmacological treatment options for COPD, COPD monitoring tools that may aid in the evaluation of disease progression and response to therapy, and the importance of developing a COPD action plan on an individualized basis.

摘要

慢性阻塞性肺疾病(COPD)是发病率和死亡率的主要原因。早期发现和适当的治疗及管理 COPD 可以降低发病率,也许还可以降低死亡率。初级保健环境中的临床医生提供了大部分 COPD 护理,在 COPD 的诊断和管理中起着关键作用。在这篇综述中,我们提供了全球倡议慢性阻塞性肺疾病(GOLD)2020 年报告的概述,重点是初级保健环境中 COPD 的管理。我们讨论了 COPD 的病理生理学;描述了可能有助于更早诊断 COPD 的 COPD 危险因素、体征和症状;并强调了在确定 COPD 诊断中使用肺活量计的重要性。还讨论了疾病监测以及对 2020 年 GOLD 治疗建议的审查。患者及其家属是 COPD 管理的重要伙伴;因此,我们概述了一些简单的步骤,以帮助他们照顾受 COPD 影响的人。最后,我们讨论了 COPD 的非药物治疗选择、可能有助于评估疾病进展和对治疗反应的 COPD 监测工具,以及制定个体化 COPD 行动计划的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/da31e984a3f4/COPD-16-289-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/c12859b0c3c3/COPD-16-289-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/7ac61c356984/COPD-16-289-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/f1760d8e9051/COPD-16-289-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/da31e984a3f4/COPD-16-289-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/c12859b0c3c3/COPD-16-289-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/7ac61c356984/COPD-16-289-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/f1760d8e9051/COPD-16-289-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c1/7886101/da31e984a3f4/COPD-16-289-g0004.jpg

相似文献

1
GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting.实践中的 GOLD:初级保健环境中的慢性阻塞性肺疾病治疗和管理。
Int J Chron Obstruct Pulmon Dis. 2021 Feb 12;16:289-299. doi: 10.2147/COPD.S222664. eCollection 2021.
2
Role of Long-Acting Muscarinic Antagonist/Long-Acting β-Agonist Therapy in Chronic Obstructive Pulmonary Disease.长效毒蕈碱拮抗剂/长效β受体激动剂疗法在慢性阻塞性肺疾病中的作用
Ann Pharmacother. 2017 Aug;51(8):696-705. doi: 10.1177/1060028017705149. Epub 2017 Apr 14.
3
A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD.当前和正在开发的固定剂量 LABA/LAMA 联合治疗 COPD 的综述。
Expert Opin Pharmacother. 2017 Dec;18(17):1833-1843. doi: 10.1080/14656566.2017.1403583. Epub 2017 Nov 15.
4
GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.GOLD 2017 治疗路径:DACCORD 观察性研究分析。
Respir Med. 2017 Oct;131:77-84. doi: 10.1016/j.rmed.2017.08.008. Epub 2017 Aug 9.
5
Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.英国基层医疗环境中初诊慢性阻塞性肺疾病患者的呼吸药物治疗使用情况:一项回顾性队列研究
COPD. 2014 Sep;11(5):521-30. doi: 10.3109/15412555.2014.922064. Epub 2014 Jun 19.
6
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.基于疾病表型,在日本慢性阻塞性肺疾病治疗中长效抗胆碱能药物/长效β2受体激动剂与吸入性糖皮质激素/长效β2受体激动剂的比较
Int J Chron Obstruct Pulmon Dis. 2015 Jun 10;10:1093-102. doi: 10.2147/COPD.S72858. eCollection 2015.
7
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.来自七个拉丁美洲国家的慢性阻塞性肺疾病(COPD)患者使用的呼吸药物:LASSYC研究
Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018.
8
Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β-agonist bronchodilators.目前有证据表明,使用长效抗胆碱能药物/长效β受体激动剂双支气管扩张剂治疗 COPD 有效。
Postgrad Med. 2020 Mar;132(2):198-205. doi: 10.1080/00325481.2019.1702834. Epub 2020 Jan 3.
9
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.灯笼研究:一项关于QVA149与沙美特罗/氟替卡松联合用药治疗慢性阻塞性肺疾病患者的随机研究。
Int J Chron Obstruct Pulmon Dis. 2015 Jun 5;10:1015-26. doi: 10.2147/COPD.S84436. eCollection 2015.
10
Inhaled treatment of COPD: a Delphi consensus statement.慢性阻塞性肺疾病的吸入治疗:一份德尔菲共识声明。
Int J Chron Obstruct Pulmon Dis. 2017 Mar 6;12:793-801. doi: 10.2147/COPD.S125564. eCollection 2017.

引用本文的文献

1
Chronic obstructive pulmonary disease is associated with higher recurrence rates of atrial fibrillation following catheter ablation.慢性阻塞性肺疾病与导管消融术后心房颤动的较高复发率相关。
Indian Pacing Electrophysiol J. 2025 May-Jun;25(3):148-156. doi: 10.1016/j.ipej.2025.05.004. Epub 2025 May 22.
2
A Retrospective Analysis of the Effects of Pneumonia and Chronic Obstructive Pulmonary Disease on Patient Mortality in Southwest Missouri.密苏里州西南部肺炎和慢性阻塞性肺疾病对患者死亡率影响的回顾性分析
Cureus. 2024 Dec 31;16(12):e76693. doi: 10.7759/cureus.76693. eCollection 2024 Dec.
3
Trends in initial pharmacological COPD treatment in primary care (2010-2021): a population-based study using the PHARMO Data Network.

本文引用的文献

1
Global Burden of Chronic Respiratory Diseases.全球慢性呼吸系统疾病负担。
J Aerosol Med Pulm Drug Deliv. 2020 Aug;33(4):171-177. doi: 10.1089/jamp.2019.1576. Epub 2020 May 18.
2
Mortality in the United States, 2017.2017年美国的死亡率。
NCHS Data Brief. 2018 Nov(328):1-8.
3
The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.吸入给药装置在慢性阻塞性肺疾病中的作用:患者与医护人员的观点
初级保健中慢性阻塞性肺疾病初始药物治疗的趋势(2010 - 2021年):一项使用PHARMO数据网络的基于人群的研究
Respir Res. 2024 Dec 30;25(1):447. doi: 10.1186/s12931-024-03073-w.
4
Clinical value of CD3CD56 natural killer cells, IL-2, and IL-8 in acute exacerbation of chronic obstructive pulmonary disease in patients with respiratory failure.CD3CD56自然杀伤细胞、白细胞介素-2和白细胞介素-8在慢性阻塞性肺疾病急性加重期合并呼吸衰竭患者中的临床价值
Am J Transl Res. 2024 Nov 15;16(11):6477-6488. doi: 10.62347/TYUO6357. eCollection 2024.
5
A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity.一个临床前-临床转化的成功案例:从氧诱导视网膜病变模型到早产儿视网膜病变的β-肾上腺素能受体阻断。
Front Physiol. 2024 Jun 13;15:1408605. doi: 10.3389/fphys.2024.1408605. eCollection 2024.
6
Evaluating the Health-Related Quality of Life in Patients with COPD and Chronic Heart Failure Post-Hospitalization after COVID-19 Using the EQ-5D and KCCQ Questionnaires.使用EQ-5D和KCCQ问卷评估COVID-19后住院的慢性阻塞性肺疾病(COPD)和慢性心力衰竭患者与健康相关的生活质量
Diseases. 2024 Jun 7;12(6):124. doi: 10.3390/diseases12060124.
7
A Chronic Obstructive Pulmonary Disease Self-Management Intervention for Improving Patient-Reported Outcomes in Primary Care in Greece.希腊的一项慢性阻塞性肺疾病自我管理干预措施,旨在改善初级保健中的患者报告结局。
Medicina (Kaunas). 2024 Feb 23;60(3):377. doi: 10.3390/medicina60030377.
8
Effects of occupational exposure to metal fume PM on lung function and biomarkers among shipyard workers: a 3-year prospective cohort study.职业性金属烟尘 PM 暴露对船厂工人肺功能和生物标志物的影响:一项为期 3 年的前瞻性队列研究。
Int Arch Occup Environ Health. 2024 May;97(4):401-412. doi: 10.1007/s00420-024-02055-1. Epub 2024 Mar 13.
9
Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories.空气中颗粒物大小与慢性阻塞性肺疾病急性加重:一项比较慢性阻塞性肺疾病全球倡议第3类和第4类的前瞻性风险因素分析。
J Pers Med. 2023 Oct 18;13(10):1505. doi: 10.3390/jpm13101505.
10
Perspectives and Attitudes of General Practitioners Towards Pharmacological and Non-Pharmacological COPD Management in a Belgian Primary Care Setting: A Qualitative Study.全科医生在比利时初级医疗环境中对 COPD 药物和非药物管理的观点和态度:一项定性研究。
Int J Chron Obstruct Pulmon Dis. 2023 Sep 25;18:2105-2115. doi: 10.2147/COPD.S423279. eCollection 2023.
Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):111-123. doi: 10.15326/jcopdf.5.2.2017.0168.
4
What is early COPD and why is it important?什么是早期 COPD 以及为什么它很重要?
Eur Respir J. 2018 Dec 6;52(6). doi: 10.1183/13993003.01448-2018. Print 2018 Dec.
5
Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.慢性阻塞性肺疾病急性加重的急诊科管理:预测再入院的因素
Int J Chron Obstruct Pulmon Dis. 2018 May 23;13:1647-1654. doi: 10.2147/COPD.S163250. eCollection 2018.
6
Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis.慢性阻塞性肺疾病(COPD)患病率的性别特异性估计:一项系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2018 May 10;13:1507-1514. doi: 10.2147/COPD.S146390. eCollection 2018.
7
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.慢性阻塞性肺疾病患者的长期三联疗法降级至茚达特罗/格隆溴铵(SUNSET):一项随机、双盲、三盲临床试验。
Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339. doi: 10.1164/rccm.201803-0405OC.
8
COPD in Primary Care: Key Considerations for Optimized Management: Dyspnea and Hyperinflation in Chronic Obstructive Pulmonary Disease: Impact on Physical Activity.基层医疗中的慢性阻塞性肺疾病:优化管理的关键考量:慢性阻塞性肺疾病中的呼吸困难与肺过度充气:对身体活动的影响
J Fam Pract. 2018 Feb;67(2 Suppl):S3-S10.
9
Office Spirometry in Primary Care for the Diagnosis and Management of COPD: National Lung Health Education Program Update.基层医疗中用于慢性阻塞性肺疾病诊断和管理的办公室肺量计检查:国家肺部健康教育计划更新
Respir Care. 2018 Feb;63(2):242-252. doi: 10.4187/respcare.05710.
10
The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.慢性阻塞性肺疾病基金会《慢性阻塞性肺疾病袖珍咨询指南》2017年更新版
Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):177-185. doi: 10.15326/jcopdf.4.3.2017.0136.